Story perspectives

Saudi Hospital Cuts CAR-T Therapy Costs by 80%

1/8/2026

44 8

Summary

Story summary

King Faisal Specialist Hospital and Research Centre (KFSHRC) localized CAR-T therapy manufacturing in Saudi Arabia, cutting costs about 80% to USD 67,000 and halving production time to two weeks.
Since 2020, KFSHRC has treated over 200 patients with CAR-T therapies.
The facility has achieved significant clinical success, including a remission case after a single dose.
KFSHRC aims to produce 2,400 doses annually to meet national demand and spur further research.

1 of 1

Story summary

King Faisal Specialist Hospital and Research Centre (KFSHRC) localized CAR-T therapy manufacturing in Saudi Arabia, cutting costs about 80% to USD 67,000 and halving production time to two weeks.
Since 2020, KFSHRC has treated over 200 patients with CAR-T therapies.
The facility has achieved significant clinical success, including a remission case after a single dose.
KFSHRC aims to produce 2,400 doses annually to meet national demand and spur further research.